Fansidar for malaria prophylaxis.
D000962:Antimalarials / Q000009:adverse effects* / Q000627:therapeutic use; D004338:Drug Combinations / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008288:Malaria / Q000517:prevention & control*; D010963:Plasmodium falciparum; D011739:Pyrimethamine / Q000009:adverse effects* / Q000627:therapeutic use; D013413:Sulfadoxine / Q000009:adverse effects* / Q000627:therapeutic use; D013424:Sulfanilamides / Q000009:adverse effects*
D000962:Antimalarials; D004338:Drug Combinations; D013424:Sulfanilamides; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D011739:Pyrimethamine